Healthcare
Medegen wins patent appeal against ICU Medical
WASHINGTON, Nov 20 (Reuters) - Medegen Inc has won a patent battle against ICU Medical Inc over a plug inserted into a catheter that prevents blood or other body fluids from getting into the line, according to a ruling issued on Thursday. Full Article
Merckle's VEM says gets 2-week moratorium
FRANKFURT, Nov 20 (Reuters) - VEM Vermoegensverwaltung, the investment vehicle of German industrialist Adolf Merckle, obtained a moratorium from about 30 banks, giving it two weeks to overhaul its finances. Full Article
Lung cancer pill may get second chance after tests
WASHINGTON, Nov 20 (Reuters) - The lung cancer pill Iressa, now used only in limited patients, has shown surprising effects in patients with advanced disease -- just as good as at least one standard chemotherapy drug, researchers reported on Thursday. Full Article
UPDATE 1-Glaxo buys AstraZeneca OTC painkiller unit
* Reflects CEO Witty's drive to broaden portfolio (Adds details) Full Article
UPDATE 1-Vanda says FDA accepts schizophrenia drug response
Nov 20 (Reuters) - Vanda Pharmaceuticals Inc said U.S. health regulators accepted the complete response for its experimental schizophrenia drug, iloperidone, sending its shares up 40 percent in pre-market trade. Full Article
CORRECTED - Dutch pick Glaxo's Cervarix for vaccine programme
(Corrects second paragraph to show Gardasil is marekted in the EU under a joint venture with Sanofi-Aventis) Full Article
UPDATE 1-Zeltia's Yondelis filed for ovarian cancer in US
MADRID, Nov 20 (Reuters) - Spanish biotechnology company Zeltia said on Thursday that its Yondelis drug has been filed for approval in the United States to treat ovarian cancer. Full Article
BRIEF-Zeltia says Yondelis filed for ovarian cancer in US
* Says Yondelis filed for ovarian cancer treatment in US Full Article
UPDATE 1-Patterson Q2 profit lags Street; cuts FY09 outlook
Nov 20 (Reuters) - Medical equipment maker Patterson Cos Inc posted lower-than-expected quarterly earnings, cut its 2009 earnings outlook and announced a freeze on its hiring and wages, citing a difficult economic environment. Full Article
UPDATE 2-Pfizer pulls EU bid to sell non-prescription Viagra
*Still believes 50mg dose meets guidelines for OTC status (Adds analyst comment, recasts) Full Article
Aetna CEO says taking market share
NEW YORK (Reuters) - Aetna Inc is confident in its prospects and is taking market share despite uncertainty over health-care reform and the broader economic climate that has weighed on its shares, the head of the No. 3 U.S. health insurer said on Wednesday. Full Article
| Symbol | Last | Net Change |
|---|---|---|
| BRENT CRUDE | $49.06 | $-2.66 |
| MINI GOLD | $748.60 | $12.70 |
| MINI SILVER | $8.98 | $-0.33 |
